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With the number of patients suffering from brain 
diseases set to soar in coming decades [1] it has become 
of great importance to not only understand normal 
functioning of the brain but also unravel when, how, 
and where in the brain deviations take place from the 
path of normal aging towards pathological degeneration 
and ultimately clinical disease. A first essential step is 
to map normal aging trajectories of the structure and 
function of the brain. This research question is as simple 
in its statement as it is complex in its operationalization. 
Magnetic resonance (MR) imaging has been the single 
most important contributor to the in vivo investigation 
of brain structure and function. Over the last three 
decades, an ever-increasing number of imaging datasets 
have become available capturing every phase of the 
human lifespan. With these datasets, trajectories of 
brain imaging markers in an aging population can be 
estimated, based on a single brain scan per subject. 
With a single measurement, taken at a single moment in 
time, merely a snapshot of the dynamic process of aging 
is taken. Considering the high inter-subject variation, 
investigating what brain aging is with only cross-
sectional data is challenging.  
While these cross-sectional studies have laid an 
important and solid foundation, to investigate brain 
aging in more depth and to better discern between 
patterns of normal versus abnormal aging, longitudinal 
data is essential to provide better insight into the timing 
and sequence of changes in aging [2]. Compared to 
cross-sectional studies, with longitudinal data one is 
able to investigate when and how the deviations from 
normal aging occur, rather than the average absolute 
differences between young and older subjects. 
Distinguishing different trajectories based on 
longitudinal data can be a starting point to study why 
certain persons show a different aging pattern than 
others, which factors drive these differences, and what 
functional outcomes these relate to.  
A frequently used approach to investigate different 
patterns of changing imaging markers over time, is to 
simply subtract measurements from two different time 
points to identify subjects that increase, decrease or 
remain stable over time. Once the subjects belonging to 
each of these categories are identified, comparing the 
population characteristics between these groups could 
point towards  potential  factors  influencing  the  trajec- 






tories. Although this approach could be an important 
first exploration, we believe that this use of longitudinal 
data is not living up to its full potential. First, 
classification of subjects into these three categories 
based on only two longitudinal measurements could be 
very sensitive to noise and therefore lead to mis-
classification. Second, the simplification of the course 
of the trajectories makes it less sensitive to detect more 
subtle slope differences. Third, though in this approach 
the slope of the subject-specific trajectories is taken into 
account, the age on which these slope differences occur 
is not. 
To give an example of how one can use longitudinal 
data to further explore different patterns of imaging 
markers, assume the hypothetical situation that we have 
identified using the method described above a poten-
tially important factor that could influence the aging 
trajectory: smoking. Figure 1A shows fictional subject-
specific trajectories of smokers and non-smokers for a 
specific imaging marker. We can then use the subject-
specific trajectories to study whether and how the 
differences in the trajectories are explained by smoking. 
Instead of assuming that everyone follows the same 
aging trajectory, only allowing for a different starting 
point (Figure 1B), approaching smoking as an effect 
modifier of the effect of age on the marker is a way to 
capture more subtle changes in the shape of the 
trajectory (Figure 1C). Even though everyone follows 
their own trajectory, the effect of smoking can be 
determined by estimating to which extent each subject-
specific trajectory is explained by smoking. Combining 
all that information gives an overall approximation of 
the effect of smoking, that would have been missed or 
underestimated when simply assuming that everyone 
has the same shape and that smoking only influences 
the intercept.  
Next to the ability to investigate different trajectories of 
a single imaging marker, longitudinal data on not just 
one, but several markers within the same subject are 
essential to assess how changes in these markers 
coincide and interact, and to assess the temporality of 
these events. In our recent work we investigated the 
trajectories and sequence of changing structural brain 
imaging markers in a large aging population, using 
longitudinal brain imaging data [3]. The resulting 
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an average sequence of the broad spectrum of normal 
aging in this population. We believe that within aging 
research, the field can take example of research 
performed in the setting of diseases with a very 
heterogeneous clinical presentation, such as multiple 
sclerosis. In these diseases, timing of events such as the 
onset of certain symptoms or presence of disease 
markers are already being used to investigate and 
identify subtypes of disease and to predict progression 
of disease. Considering that we may never be able to 
draw a clear line between normal aging and abnormal 
aging, we believe that with a special focus on the timing 
and sequence of events in brain aging, we may also be 
able to identify different patterns of aging in a similar 
way. This could greatly advance research into brain 
health in old age. 
To summarize, more imaging data on the same subjects 
gives us the opportunity to  focus on timing and 
sequences of changes, which can help us to identify 
different patterns within the broad spectrum of normal 
aging. This would bring us one step closer towards 
understanding the sources of variability, and their 
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Figure 1. Fictional subject‐specific trajectories of an imaging marker in aging, from smokers and non‐smokers (A), with population‐based
trajectories assuming that every subject follows the same trajectory only allowing for a different starting point (B) and population‐based
trajectories with smoking as an effect modifier (C). 
 
